Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer

被引:0
|
作者
Vanasek, J. [1 ,7 ,8 ]
Odrazka, K. [1 ,8 ]
Dusek, L. [2 ,3 ]
Jarkovsky, J. [2 ,3 ]
Michalek, R. [6 ]
Chrobok, V. [4 ,5 ]
Dolezel, M. [1 ]
Kolarova, I. [1 ,7 ,8 ]
机构
[1] Oncol Ctr Multiscan, Pardubice, Czech Republic
[2] Masaryk Univ, Fac Med, Inst Biostat & Analyses, Brno, Czech Republic
[3] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic
[4] Charles Univ Prague, Univ Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Hradec Kralove, Czech Republic
[5] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic
[6] Reg Hosp, Otorhinolaryngol & Head & Neck Surg Clin, Pardubice, Czech Republic
[7] Pardubice Univ, Fac Hlth Studies, Pardubice, Czech Republic
[8] Fac Mil Hlth Sci, Dept Radiobiol, Hradec Kralove, Czech Republic
来源
JOURNAL OF BUON | 2013年 / 18卷 / 04期
关键词
head and neck cancer; IMRT; radiotherapy; relapse; survival; RADIATION-THERAPY; IMRT; PATTERNS; CARCINOMA; FAILURE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Studies using intensity-modulated radiation therapy (IMRT) in the treatment of head and neck tumors have shown to decrease acute and late radiation toxicity. However, the high conformity of this technique can increase the risk of recurrence due to geographic miss. The aim of this study was to analyze whether the results of IMRT met the theoretical expectations concerning treatment efficacy. Methods: From a total of 185 patients (152 males and 33 females, mean age 58+/-10.36 years) 176 were evaluable and were studied. Eighty-nine (48.1%) patients had surgical treatment and 50 of them were scheduled for concomitant cisplatin chemotherapy. Irradiation was performed using IMRT, a sliding window with 9 fields in a Varian 2100 C/D linear accelerator, X-ray beam, 6 MeV. The prescribed dose in the planning treatment volume (PTV1), i.e., the area of the primary tumor and nodal area, was 66 Gy/2.2 Gy-70 Gy/2.12 Gy. In the PTV2 (the area at high risk) the dose was 60Gy/2 Gy-59.4 Gy/ 1.8 Gy, and in the PTV 3 (the area treated with prophylactic irradiation) the prescribed dose was 54 Gy/1.8 Gy-50.4 Gy/1.53 Gy. Results: The 3-year overall survival (OS) and relapse-free survival (RFS) of IMRT-treated patients, most of whom were in stages III and IV (158 out of 177), were 50 and 57%, respectively. Using postoperative radiotherapy/chemoradiotherapy 3-year locoregioncal control was achieved in 75% of the cases as compared with 35% in non-operated patients. Conclusions: The worst outcomes were found in oral cavity and hypopharyngeal tumors, and the best in laryngeal and oropharyngeal tumors. Better results were found in surgically treated patients, and in lower disease stages. Despite the high conformity of dose distribution and efforts to spare healthy tissues, most cases of locoregional relapse occurred in areas receiving the full radiation dose. If dividing relapses into cases of persistence and local recurrence, the former predominated.
引用
收藏
页码:970 / 976
页数:7
相关论文
共 50 条
  • [1] The role of intensity-modulated radiotherapy in head and neck cancer
    Bhide, S. A.
    Kazi, R.
    Newbold, K.
    Harrington, K. J.
    Nutting, C. M.
    [J]. INDIAN JOURNAL OF CANCER, 2010, 47 (03) : 267 - 273
  • [2] REIRRADIATION WITH INTENSITY-MODULATED RADIOTHERAPY IN RECURRENT HEAD AND NECK CANCER
    Zwicker, Felix
    Roeder, Falk
    Hauswald, Henrik
    Thieke, Christian
    Timke, Carmen
    Schlegel, Wolfgang
    Debus, Juergen
    Muenter, Marc W.
    Huber, Peter E.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1695 - 1702
  • [3] Clinical application of intensity-modulated radiotherapy for head and neck cancer
    Olivier Ballivy
    Ramón Galiana Santamaría
    Alicia Lozano Borbalas
    Ferrán Guedea Edo
    [J]. Clinical and Translational Oncology, 2008, 10 : 407 - 414
  • [4] Clinical application of intensity-modulated radiotherapy for head and neck cancer
    Ballivy, Olivier
    Santamaria, Ramon Galiana
    Borbalas, Alicia Lozano
    Edo, Ferran Guedea
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (07): : 407 - 414
  • [5] Intensity-modulated radiotherapy in head and neck cancer: Ethics and methodology
    Lapeyre, M.
    Biau, J.
    Miroir, J.
    Servagi-Vernat, S.
    Giraud, P.
    [J]. CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 365 - 368
  • [6] Intensity-modulated radiotherapy for head and neck surgeons
    Gutiontov, Stanley I.
    Shin, Edward J.
    Lok, Benjamin
    Lee, Nancy Y.
    Cabanillas, Ruben
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E2368 - E2373
  • [7] Contemplation of head and neck intensity-modulated radiotherapy
    Rose, T.
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2008, 7 (02) : 61 - 66
  • [8] Intensity-modulated radiotherapy for carcinoma of the head and neck
    José A. Peñagarícano
    Niko Papanikolaou
    [J]. Current Oncology Reports, 2003, 5 (2) : 131 - 139
  • [9] A comparison of forward and inverse treatment planning for intensity-modulated radiotherapy of head and neck cancer
    Bär, W
    Schwarz, M
    Alber, M
    Bos, LJ
    Mijnheer, BJ
    Rasch, C
    Schneider, C
    Nüsslin, F
    Damen, EMF
    [J]. RADIOTHERAPY AND ONCOLOGY, 2003, 69 (03) : 251 - 258
  • [10] Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers
    Bhide, Sheerang A.
    Newbold, Kate L.
    Harrington, Kevin J.
    Nutting, Chris M.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (03) : 297 - 300